Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.74B | 27.61B | 25.85B | 23.76B | 20.49B |
Gross Profit | 5.33B | 3.99B | 4.25B | 4.07B | 3.02B |
EBITDA | 2.66B | 1.62B | 2.13B | 2.30B | 1.32B |
Net Income | 1.58B | 873.28M | 1.29B | 1.41B | 783.52M |
Balance Sheet | |||||
Total Assets | 33.29B | 25.04B | 23.10B | 19.49B | 13.96B |
Cash, Cash Equivalents and Short-Term Investments | 7.17B | 6.25B | 5.97B | 6.01B | 4.57B |
Total Debt | 22.88B | 17.08B | 15.24B | 12.08B | 8.68B |
Total Liabilities | 26.06B | 19.04B | 17.53B | 14.79B | 10.44B |
Stockholders Equity | 7.23B | 5.99B | 5.57B | 4.71B | 3.52B |
Cash Flow | |||||
Free Cash Flow | -4.57B | -591.05M | -2.72B | -1.66B | 2.01B |
Operating Cash Flow | -4.56B | -588.50M | -2.69B | -1.65B | 2.01B |
Investing Cash Flow | 37.90M | -493.47M | -52.06M | -64.49M | 9.06M |
Financing Cash Flow | 5.44B | 1.36B | 2.70B | 3.16B | 140.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥9.95B | 5.18 | 3.53% | 13.64% | 128.96% | ||
76 Outperform | ¥11.19B | 7.08 | 4.78% | 11.37% | 80.95% | ||
75 Outperform | ¥11.55B | 14.17 | 4.51% | 5.06% | 20.57% | ||
72 Outperform | ¥9.73B | 10.58 | 5.36% | 11.64% | -30.52% | ||
67 Neutral | ¥12.23B | 29.18 | ― | 15.18% | -14.01% | ||
64 Neutral | ¥9.86B | 52.57 | 3.92% | 0.43% | -91.24% | ||
59 Neutral | C$1.25B | -2.64 | -8.19% | 5.08% | 10.84% | -18.98% |